4//SEC Filing
HEMOBIOTECH, INC. 4
Accession 0001140361-08-024228
CIK 0001301348operating
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 4:31 PM ET
Size
9.5 KB
Accession
0001140361-08-024228
Insider Transaction Report
Form 4
HEMOBIOTECH, INC.HMBT.OB
Bollon Arthur
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock, par value $0.001 per share
2008-10-30$1.00/sh−130,334$130,334→ 1,768,837 total - Exercise/Conversion
Common Stock, par value $0.001 per share
2008-10-30$0.20/sh+651,668$130,334→ 1,899,171 total - Exercise/Conversion
Options to Purchase Common Stock
2008-10-30−651,668→ 100,000 totalExercise: $0.20Exp: 2008-10-31→ Common Stock, par value $0.001 per share (651,668 underlying)
Footnotes (2)
- [F1]The Reporting Person exercised a stock option to purchase 651,668 shares of Common Stock and paid the exercise price thereof by the surrender of 130,334 shares of Common Stock, for a net gain in outstanding shares of Common Stock of 521,334 shares. The stated exercise price of the stock option was $0.20
- [F2]Options granted to reporting person as of 10/31/03. All 651,668 options have vested as of 10/30/2008
Documents
Issuer
HEMOBIOTECH, INC.
CIK 0001301348
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001301348
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 4:31 PM ET
- Size
- 9.5 KB